A Randomized Study of 6 Vs 3 Years of Adjuvant Imatinib in Patients with Localized GIST at High Risk of Relapse.
J. -y. Blay,C. Schiffler,O. Bouche,M. Brahmi,F. Duffaud,M. Toulmonde,B. Landi,W. Lahlou,D. Pannier,E. Bompas,F. Bertucci,L. Chaigneau,O. Collard,M. Pracht,C. Henon,I. Ray-Coquard, K. Armoun,S. Salas,M. Spalato-Ceruso,A. Adenis,B. Verret,N. Penel, C. Moreau-Bachelard,A. Italiano,A. Dufresne,S. Metzger,S. Chabaud,D. Perol,A. Le Cesne ANNALS OF ONCOLOGY（2024）
关键词
adjuvant therapy,gastrointestinal stromal tumors,imatinib mesylate,randomized clinical trial
AI 理解论文
溯源树
样例
